John Kenneth Morrow

Statistics

Publications

Citations

737

H-Index

Active since

2010

Affiliations

The University of Texas MD Anderson Cancer Center(Current)

University of Houston

Chi Mei Medical Center

National Health Research Institutes

China Medical University

John Kenneth Morrow is an author at The University of Texas MD Anderson Cancer Center specializing in drug design, medicinal chemistry, and drug discovery.

ORCID

Publications per year

2010–2023

Publications

Pharmacological Inactivation of Skp2 SCF Ubiquitin Ligase Restricts Cancer Stem Cell Traits and Cancer Progression

Chia‐Hsin Chan, John Kenneth Morrow, Chien‐Feng Li et al. · Cell · 2013 · 393 citations · Full text

Medicine, Cancer Biology, Cell Biology +12

The critical role of AMPK in driving Akt activation under stress, tumorigenesis and drug resistance

Fei Han, Chien‐Feng Li, Zhen Cai et al. · Nature Communications · 2018 · 187 citations · Full text

Life Sciences, Molecular Biology, Oncology +17

Fragment-based Differential Targeting of PPI Stabilizer Interfaces

X. Guillory, M. Wolter, S. Leysen et al. · Journal of Medicinal Chemistry · 2020 · 50 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +17

Three-Dimensional Quantitative Structure-Activity Relationship Studies on UGT1A9-Mediated 3-O-Glucuronidation of Natural Flavonols Using a Pharmacophore-Based Comparative Molecular Field Analysis Model

Baojian Wu, John Kenneth Morrow, Rashim Singh et al. · Journal of Pharmacology and Experimental Therapeutics · 2010 · 39 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +15

SULT1A3-Mediated Regiospecific 7-O-Sulfation of Flavonoids in Caco-2 Cells Can Be Explained by the Relevant Molecular Docking Studies

Shengnan Meng, Baojian Wu, Rashim Singh et al. · Molecular Pharmaceutics · 2012 · 29 citations

Life Sciences, Biochemistry, Pharmacology +13

1–5 of 7